Condition
HIV (Human Immunodeficiency Virus) clinical trials and research
As of November 12, 2026, Find a Trial lists 16 HIV (Human Immunodeficiency Virus) clinical trials that are recruiting, at sites in 12 countries (most in United States (4), France (2), Mexico (1)). 2 were first registered in the last 30 days. By phase: Phase 2 (4), Phase 4 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 2New in 30 days
- 12Countries
Newest HIV (Human Immunodeficiency Virus) clinical trials
All recruiting trials (16)
-
Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide
This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.
-
Multiple interventions to try for HIV remission in people on ART
This study tests a combination approach, including intensified ART, latency-reversal agents, and autologous dendritic cell therapy, to see if people living with HIV on long-term ART can achieve sustained viral suppression or prolonged remission.
-
Portable chest X-ray screening to rapidly find TB in migrants
A community-based TB screening effort using mobile chest X-rays and AI-assisted readings is tested among migrant adults in New York City to see if it helps identify active TB earlier and connect people to care.
-
Two-probe thermal ablation for cervical precancer in WLWH in South Africa
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in South Africa.
-
Two-probe thermal ablation for cervical precancer in WLWH in Zimbabwe
This study tests whether using two TA probes (endocervical and ectocervical) is better than one probe for treating cervical precancer in women living with HIV in Zimbabwe.
-
TransAction program to improve HIV prevention and care for transgender women in Ho Chi Minh City
This trial will test whether TransAction—individual risk-reduction sessions, skill-building and group support, plus social events—helps transgender women in Ho Chi Minh City move forward in HIV prevention and care compared with social events alone.
-
Restarting HIV treatment with a single-pill regimen (B/F/TAF) after a treatment gap
This study tests whether quickly restarting ART with the single-pill regimen B/F/TAF is safe and effective for people with HIV who have had a treatment interruption of at least 12 weeks.
-
Two-probe thermal ablation for cervical precancer in HIV+ women in Kenya
This study tests whether using two probes for thermal ablation is more effective and acceptable than one probe for treating cervical precancer in women living with HIV in Kenya.
-
Two-probe thermal ablation for cervical precancer in WLWH in Rwanda
This study tests whether using two probes for thermal ablation is safer or more effective than one probe for treating cervical precancer in women living with HIV in Rwanda.
-
Empagliflozin for metabolic health in adults with HIV on dolutegravir
This trial tests whether the diabetes medicine empagliflozin can help reduce obesity-related metabolic problems in adults living with HIV who are taking dolutegravir-based antiretroviral therapy.
-
Reexamining how asymptomatic tuberculosis spreads
This project will test whether people with asymptomatic tuberculosis—particularly adults living with HIV—can pass TB to their household and close contacts.
-
Boosting Smell Training in Adults with HIV
This study tests two at-home smell-training methods to see if they improve scent function and thinking skills in adults with HIV.
-
PrEP given with opioid replacement therapy at community pharmacies
This project will test whether giving daily oral PrEP together with opioid agonist therapy at community pharmacies is practical and acceptable for HIV-negative people on opioid replacement therapy who are at risk.
-
Resmetirom treatment for adults with MASLD and HIV
This study will test whether taking resmetirom daily for 24 weeks lowers liver fat in adults who have MASLD and well-controlled HIV on antiretroviral therapy.
-
Doravirine/TDF/3TC versus Bictegravir/FTC/TAF for adults with HIV who are overweight or obese
This trial will test whether a doravirine-based HIV pill or a bictegravir-based HIV pill leads to less weight gain in adults with HIV who are overweight or obese starting antiretroviral therapy.
-
Measuring HIV drug levels in hair to find missed or stopped doses
This project tries to see if measuring levels of emtricitabine or lamivudine in hair can tell whether adults with HIV are missing doses or have stopped their medicine.
Related topics
Quick answers
How many HIV (Human Immunodeficiency Virus) clinical trials are recruiting right now?
16, as of November 12, 2026. 2 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (4 trials), France (2 trials), Mexico (1 trial), Egypt (1 trial), Kenya (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 4: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.